Back to Journals » Psoriasis: Targets and Therapy » Volume 11 » Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
Please verify you are not a robot.